Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.
about
Understanding breast cancer - The long and winding road.Evaluation and optimization of reduction and alkylation methods to maximize peptide identification with MS-based proteomics.Differential expression of NPM, GSTA3, and GNMT in mouse liver following long-term irradiation by means of uranium tailings
P2860
Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Advancement of mass spectromet ...... triple negative breast cancer.
@en
Advancement of mass spectromet ...... triple negative breast cancer.
@nl
type
label
Advancement of mass spectromet ...... triple negative breast cancer.
@en
Advancement of mass spectromet ...... triple negative breast cancer.
@nl
prefLabel
Advancement of mass spectromet ...... triple negative breast cancer.
@en
Advancement of mass spectromet ...... triple negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Advancement of mass spectromet ...... triple negative breast cancer
@en
P2093
Kiven E Lukong
Mark K Adams
Michael P Washburn
Sayem Miah
P2860
P356
10.1039/C6MB00639F
P577
2016-12-01T00:00:00Z